Fig. 3
From: Development and validation of circulating CA125 prediction models in postmenopausal women
Development and validation of the dichotomous CA125 prediction model. Receiver Operating Characteristic (ROC) curves were plotted and the Area Under the Curve (AUC) were calculated to assess the discriminatory performance of the dichotomous CA125 prediction model in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) (solid line) and Nurses’ Health Studies (NHS/NHSII) / New England Case Control Study (NEC) (dashed line)